BiotechTube
Home/Valitor/Gregory D. Kunst
GD

Gregory D. Kunst

Chief Executive Officer

Valitor

Therapeutic Areas

Ophthalmology

Valitor Pipeline

DrugIndicationPhase
VLTR-559Wet Age-Related Macular Degeneration (wet AMD)Pre-clinical

Leadership Team at Valitor

WJ
Wesley Jackson, PhD
President, Chief Scientific Officer & Member of the Board
WS
William S. (Sandy) White, PharmD, MBA
Executive Development Advisor
OJ
Omkar Joshi, PhD
Chief Technical Officer
View full Valitor profile